Showing results (11-20 of 22) with videos related to
Sort By:
Pageof 3
International Journal of Molecular Sciences|August 26, 2022
Multi-Level Control of the ATM/ATR-CHK1 Axis by the Transcription Factor E4F1 in Triple-Negative Breast CancerKalil Batnini, Thibault Houles, Olivier Kirsh, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|February 26, 2009
Do evolving practices improve survival in operated lung cancer patients? A biobank may answerFotis Vlastos, Stéphanie Lacomme, Pascal Wild, et al.International Journal of Cancer|May 17, 2019
Distinct oncogenes drive different genome and epigenome alterations in human mammary epithelial cellsClaire Fonti, Anne Saumet, Amanda Abi-Khalil, et al.Scientific Data|July 4, 2025
MelanoDB: A dataset of clinical and molecular features of patients with advanced melanoma treated with MAPK inhibitorsSarah Dandou, Julie A Vendrell, Jérôme Solassol, et al.Oncotarget|September 4, 2015
Ovarian carcinoma patient derived xenografts reproduce their tumor of origin and preserve an oligoclonal structurePierre-Emmanuel Colombo, Stanislas du Manoir, Béatrice Orsett, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 8, 2016
Therapeutic Activity of Anti-AXL Antibody against Triple-Negative Breast Cancer Patient-Derived Xenografts and MetastasisWilhem Leconet, Myriam Chentouf, Stanislas du Manoir, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 6, 2016
Circulating DNA as a Strong Multimarker Prognostic Tool for Metastatic Colorectal Cancer Patient Management CareSafia El Messaoudi, Florent Mouliere, Stanislas Du Manoir, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|October 19, 2023
Gadolinium-Based Nanoparticles Sensitize Ovarian Peritoneal Carcinomatosis to Targeted Radionuclide TherapyClara Diaz Garcia-Prada, Léna Carmes, Salima Atis, et al.Oncotarget|January 27, 2018
The IL-17B-IL-17 receptor B pathway promotes resistance to paclitaxel in breast tumors through activation of the ERK1/2 pathwayEmilie Laprevotte, Stéphanie Cochaud, Stanislas du Manoir, et al.Theranostics|May 17, 2021
A 9-kDa matricellular SPARC fragment released by cathepsin D exhibits pro-tumor activity in the triple-negative breast cancer microenvironmentLindsay B Alcaraz, Aude Mallavialle, Timothée David, et al.Pageof 3